UBS Group’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$176M Sell
1,200,416
-317,986
-21% -$49M 0.03% 680
2025
Q4
$235M Buy
1,518,402
+365,502
+32% +$54.7M 0.04% 498
2025
Q3
$160M Sell
1,152,900
-79,100
-6% -$10.7M 0.03% 706
2025
Q2
$166M Buy
1,232,000
+405,800
+49% +$54.8M 0.03% 629
2025
Q1
$121M Sell
826,200
-83,200
-9% -$12.1M 0.02% 809
2024
Q4
$125M Buy
909,400
+380,300
+72% +$55.7M 0.02% 778
2024
Q3
$81.5M Buy
529,100
+398,600
+305% +$60.4M 0.02% 846
2024
Q2
$19M Sell
130,500
-555,900
-81% -$79.7M ﹤0.01% 1725
2024
Q1
$101M Buy
686,400
+567,300
+476% +$81.4M 0.03% 640
2023
Q4
$16.2M Sell
119,100
-184,900
-61% -$24.1M ﹤0.01% 1732
2023
Q3
$39.1M Sell
304,000
-114,700
-27% -$15.2M 0.01% 1005
2023
Q2
$55.6M Sell
418,700
-155,300
-27% -$20.5M 0.02% 773
2023
Q1
$74.3M Buy
574,000
+360,800
+169% +$47.1M 0.03% 577
2022
Q4
$29M Sell
213,200
-357,100
-63% -$47.3M 0.01% 1160
2022
Q3
$69.1M Buy
570,300
+105,000
+23% +$13.5M 0.03% 557
2022
Q2
$59.7M Buy
465,300
+217,800
+88% +$28.5M 0.02% 638
2022
Q1
$33.9M Sell
247,500
-681,800
-73% -$90.3M 0.01% 1082
2021
Q4
$131M Sell
929,300
-1,111,400
-54% -$148M 0.04% 491
2021
Q3
$260M Buy
2,040,700
+186,900
+10% +$24.7M 0.08% 241
2021
Q2
$233M Buy
1,853,800
+503,800
+37% +$61.7M 0.08% 260
2021
Q1
$158M Sell
1,350,000
-1,200
-0.1% -$139K 0.05% 342
2020
Q4
$153M Buy
1,351,200
+230,800
+21% +$25.2M 0.05% 349
2020
Q3
$118M Buy
1,120,400
+1,011,700
+931% +$106M 0.04% 356
2020
Q2
$10.9M Sell
108,700
-16,300
-13% -$1.61M ﹤0.01% 1439
2020
Q1
$11.1M Sell
125,000
-50,000
-29% -$4.86M 0.01% 1331
2019
Q4
$17.8M Sell
175,000
-263,100
-60% -$25.3M 0.01% 1461
2019
Q3
$39.5M Buy
438,100
+339,500
+344% +$31M 0.02% 813
2019
Q2
$9.13M Buy
98,600
+70,000
+245% +$6.29M ﹤0.01% 1833
2019
Q1
$2.62M Buy
28,600
+20,700
+262% +$1.87M ﹤0.01% 2751
2018
Q4
$683K Buy
7,900
+4,300
+119% +$389K ﹤0.01% 4018
2018
Q3
$343K Hold
3,600
﹤0.01% 4664
2018
Q2
$300K Sell
3,600
-745,000
-100% -$61.7M ﹤0.01% 4688
2018
Q1
$60.9M Sell
748,600
-233,100
-24% -$19.9M 0.03% 546
2017
Q4
$81.2M Buy
981,700
+557,100
+131% +$45.9M 0.03% 478
2017
Q3
$34.7M Buy
424,600
+418,600
+6,977% +$33.6M 0.02% 797
2017
Q2
$475K Sell
6,000
-315,000
-98% -$24M ﹤0.01% 4146
2017
Q1
$23.9M Sell
321,000
-1,085,100
-77% -$79.1M 0.01% 924
2016
Q4
$96.9M Buy
1,406,100
+259,200
+23% +$18M 0.05% 340
2016
Q3
$82.7M Buy
1,146,900
+230,900
+25% +$17M 0.05% 369
2016
Q2
$65.7M Buy
916,000
+122,500
+15% +$8.63M 0.04% 406
2016
Q1
$53.8M Sell
793,500
-2,700
-0.3% -$181K 0.04% 444
2015
Q4
$57.4M Hold
796,200
0.04% 467
2015
Q3
$52.7M Sell
796,200
-403,600
-34% -$29.5M 0.04% 451
2015
Q2
$89.3M Buy
1,199,800
+301,400
+34% +$22.3M 0.06% 332
2015
Q1
$65.1M Buy
898,400
+886,000
+7,145% +$63.2M 0.05% 426
2014
Q4
$848K Buy
+12,400
New +$830K ﹤0.01% 3708

Other funds holding XLV

UBS Group's XLV Position: Q1 2026 in Review

UBS Group reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 4.1% in Q1 2026, selling an estimated $29.9M and leaving 4,528,081 shares worth $664M. The position accounts for 0.1% of the portfolio, ranked #200.

UBS Group first reported a position in XLV in Q4 2014 and has held it in 46 quarters since. The position peaked at $731M in Q4 2025. 1,802 funds tracked by Wall St. Rank hold XLV as of Q1 2026.

  • UBS Group held 4,528,081 shares of State Street Health Care Select Sector SPDR ETF worth $664M as of Q1 2026.
  • UBS Group sold 193,663 State Street Health Care Select Sector SPDR ETF shares in Q1 2026, an estimated $29.9M.
  • State Street Health Care Select Sector SPDR ETF made up 0.1% of UBS Group's portfolio in Q1 2026, its #200 holding.
  • UBS Group first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's State Street Health Care Select Sector SPDR ETF position peaked at $731M in Q4 2025.
  • 1,802 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.